HB 1147 South Dakota House · 2024 Regular Session

address discriminatory acts against entities participating in a 340B drug pricing program.

Bill status signed all 5 stages cleared

Introduction

Jan 2024

Committee Review

Feb 2024

House Passage

Feb 2024

Senate Passage

Feb 2024

Signed into Law

Mar 2024

Introduced Jan 25, 2024 Signed Mar 5, 2024

Floor votes · House Feb 12, 2024

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 5, 2024

Signed into law

Signed by the Governor on 2024-03-05 H.J. 474

executive

Feb 26, 2024

Upper · Passed

Signed by the President S.J. 418

upper

Feb 23, 2024

Upper · Passed

Signed by the Speaker H.J. 393

upper

Feb 22, 2024

Upper · Passed

Senate Do Pass , Passed, YEAS 34, NAYS 0 S.J. 387

upper

Feb 21, 2024

Upper · Passed

Certified uncontested, placed on consent , Passed,

upper

Feb 21, 2024

Upper · Passed

Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0

upper

Feb 13, 2024

Introduced

First read in Senate and referred to S.J. 311

upper

Feb 12, 2024

Lower · Passed

House of Representatives Do Pass , Passed, YEAS 68, NAYS 1 H.J. 308

lower

Feb 8, 2024

Lower · Passed

House of Representatives Deferred to another day , Passed, H.J. 299

lower

Feb 7, 2024

Lower · Passed

Commerce and Energy Do Pass , Passed, YEAS 12, NAYS 0

lower

Jan 25, 2024

Introduced

First read in House and referred to H.J. 174

lower

12 primary · 0 co-sponsors